Narrow Results

Can Chinese Medicine and Biomedicine Converge?

Integrative Medicine: East Meets West.

Ginseng: Nature’s “Cure-All”.

Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreements for Leading Anti-emetic Products in Middle East, Africa, Latin America and Indonesia.

Leading Regional Medical Technology Trade Associations Reinforce their Commitment to Evidence-based Healthcare.

Lonza Expands Airway Disease Portfolio with Addition of IPF Airway Cells.

Boston Scientific Launches Interventional Cardiology Online Education Portal for Physicians.

Pfizer Presented Data from PALOMA-2 Phase 3 Study Demonstrating Clinical Benefit of IBRANCE^® (palbociclib) in Asian Women with ER+, HER2- Metastatic Breast Cancer.

Global Healthcare Systems at Pivotal Point as Technology Offers Solutions to Industry Challenges – The Economist Intelligence Unit.

Cellectricon and Censo Biotechnologies Introduce a Joint Technology Access Program Utilizing High-Quality Human iPSC-based Discovery Services for CNS and Pain Research.

Drones, Robots and Food.

Finding PALE GREEN1, a Missing Piece of the Vitamin B1 Biosynthesis Pathway.

Death by Medical Errors: How Evidence-based Information Can Save Lives (Interview with Dr Ujjwal Rao, Clinical Specialist at Elsevier).

The following topics are under this section:

• Dawn of the Big Machine
• Overcoming Cultural Barriers to SSI Prevention Guidelines

Values-based management and evidence-based innovation management both improve a company’s innovation performance. However, there are no systematic studies of how combining values-based and evidence-based innovation management influences the innovation culture in mid-sized B2B companies. In this exploratory case study, we describe how a longitudinal analysis of innovation culture and a values-based initiative were combined in a 7-step approach, which was applied in a global mid-sized B2B manufacturer of drug-delivery systems and pharmaceutical components over a three-year period. The results of the longitudinal innovation culture survey and the analysis of front-end innovation key performance indicators provided insight into the positive impact of new normative company values on the organisation’s innovation culture as well as on the effectiveness of the idea generation process. The exploratory case study demonstrates how a customised combination of values-based and evidence-based innovation management elements can systematically strengthen an organisation’s innovation culture and the effectiveness of its idea generation process.

Currently more than half of all Australians use one or more complementary and alternative medicine (CAM) items year by year. At the same time, sales of CAM materials exceed the cost of conventional medicines. So well established is CAM culture, that it is time medical and surgical professionals took more notice of its extensive role in medical care. At this time there is strong interest in having all conventional medical activity evidence-based. Although CAM has been the subject of many randomised controlled trials, and some have been accepted into integrated practice, most lack the rigour in their development to render them acceptable in day-to-day practice. It is suggested that, in spite of these observations, the continued pressure arising from increasing usage of CAM therapies, together with patients' expectations, should be given greater consideration in integration with conventional medicine, while ensuring maintenance of standards. This will not be an easy task. As CAM usage may result in deleterious outcomes, it is imperative that its use is elicited when taking a patient's history. The consultation should be conducted in an atmosphere of mutual respect and understanding, to discourage the patient from withholding information. When possible, clinicians should be apprised of CAM agents that have adverse interactions with standard treatments and of CAM agents that may be dangerous. As CAM is now clearly established in the public domain, it would seem that appropriate steps should be taken to educate clinicians in CAM, by introducing changes to undergraduate curricula. Such a move may lead to better understanding at medical and community level.

Offenders with mental health disorders have been on the rise and research shows that they present with complex challenges to the prison system across the world (Jüriloo, Pesonen, & Lauerma, 2017). Specifically, inmates with severe mental disorders who are convicted of sexual and violent offences have been found to present with complex challenges to mental health providers and prison staff during intervention programmes and community supervision as such it is vital that these programmes continue to evolve and improvise (Baillargeon et al., 2010; Cloyes et al., 2010; Cuddeback et al., 2019). This chapter seeks to document the programmes and processes within the Singapore Prison Service pertaining to the treatment and intervention of inmates with mental disorders. Specifically, the valuable work of the Clinical Psychology Unit and its collaborations with various specialised housing units seek to rehabilitate these offenders with mental health disorders based on multi-disciplinary and evidence-based approaches.